NCT06770894
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Bone Loss, Postmenopausal, +10 more
- Locations
-
- AOU Policlinico Umberto I, University La Sapienza Rome, Italy
Clinical trial condition
Osteoporosis
Explore clinical trials studying Osteoporosis. Study availability and eligibility vary by location and protocol.
1,217 public trials
103 recruiting studies
Osteoporosis trial results
NCT06760598
- Conditions
- Atrophy, Bone Diseases, Bone Diseases, Metabolic, +17 more
- Locations
-
- Istanbul University Cerrahpasa Istanbul, Turkey (Türkiye)
- Istanbul University Cerrahpasa, Cerrahpasa Medical Faculty Istanbul, SÜLEYMANPAŞA, Turkey (Türkiye)
Completed
Insomnia in Postmenopausal Osteoporosis
NCT06646549
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- Beylikdüzü State Hospital Istanbul, Beylikdüzü, Turkey (Türkiye)
- Beylikdüzü State Hospital Istanbul, Turkey (Türkiye)
NCT05328154
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- CHU clermont-ferrand Clermont-Ferrand, France
NCT06624657
- Conditions
- Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +15 more
- Locations
-
Not specified
Completed
Bone Health in Aging HIV Infected Women
NCT02815566
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, HIV, +5 more
- Locations
-
- Vancouver ID Research and Care Centre Vancouver, British Columbia, Canada
- Hamilton Health Sciences Hamilton, Ontario, Canada
- University Health Network Toronto, Ontario, Canada
- McGill University Health Centre Montreal, Quebec, Canada
NCT05316272
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Low Bone Density, +4 more
- Locations
-
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
NCT00643331
- Conditions
- Behavior, Bone Diseases, Bone Diseases, Metabolic, +6 more
- Locations
-
- University of Melbourne Melbourne, Victoria, Australia
NCT05067335
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- Op0002 20040 Beijing, China
- Op0002 20115 Beijing, China
- Op0002 20125 Beijing, China
- Op0002 20127 Beijing, China
Completed
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
NCT04338529
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- 251 Hellenic Air Force & VA General Hospital Athens, Attica, Greece